Weiyi Peng

Weiyi Peng

UNVERIFIED PROFILE

Are you Weiyi Peng?   Register this Author

Register author
Weiyi Peng

Weiyi Peng

Publications by authors named "Weiyi Peng"

Are you Weiyi Peng?   Register this Author

35Publications

1365Reads

47Profile Views

Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.

Cancer Immunol Immunother 2019 Sep 12;68(9):1515-1526. Epub 2019 Sep 12.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 1155 Pressler St, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02385-xDOI Listing
September 2019

The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma.

Clin Cancer Res 2019 03 11;25(5):1650-1663. Epub 2018 Dec 11.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-1163DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397703PMC
March 2019

Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer.

Nat Commun 2019 02 22;10(1):899. Epub 2019 Feb 22.

Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-08782-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385305PMC
February 2019

Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications.

Pigment Cell Melanoma Res 2018 01 2;31(1):11-30. Epub 2017 Nov 2.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12661DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742019PMC
January 2018

Complementing T-cell Function: An Inhibitory Role of the Complement System in T-cell-Mediated Antitumor Immunity.

Cancer Discov 2016 09;6(9):953-5

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-16-0698DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069599PMC
September 2016

Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells.

Sci Signal 2016 09 27;9(447):ra94. Epub 2016 Sep 27.

Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061503PMC
http://dx.doi.org/10.1126/scisignal.aaf3957DOI Listing
September 2016

Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer--letter.

Clin Cancer Res 2013 Oct 18;19(19):5541. Epub 2013 Sep 18.

Authors' Affiliations: Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas; and Cutaneous Oncology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823378PMC
October 2013

Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer.

Oncoimmunology 2013 Feb;2(2):e22691

Department of Melanoma Medical Oncology; The Center for Cancer Immunology Research; The University of Texas MD Anderson Cancer Center; Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.22691DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601154PMC
February 2013

Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40.

Blood 2012 Nov 30;120(23):4533-43. Epub 2012 Aug 30.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-02-407163DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512233PMC
November 2012

PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines.

Cancer Res 2012 Oct 20;72(20):5209-18. Epub 2012 Aug 20.

Department of Melanoma Medical Oncology, The Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-12-1187DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476734PMC
October 2012

Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo.

J Immunother 2012 Apr;35(3):276-82

Department of Melanoma Medical Oncology, The Center for Cancer Immunology Research, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e31824e7f43DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860320PMC
April 2012

Antitumor activity mediated by CpG: the route of administration is critical.

J Immunother 2011 Apr;34(3):279-88

Department of Melanoma Medical Oncology, The Center for Cancer Immunology Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e31820d2a05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119202PMC
April 2011

Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses.

Clin Cancer Res 2010 Nov 1;16(22):5458-68. Epub 2010 Oct 1.

Departments of Melanoma Medical Oncology and Experimental Diagnostic Imaging, The Center for Cancer Immunology Research, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-10-0712DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476703PMC
November 2010

Tumor-associated galectin-3 modulates the function of tumor-reactive T cells.

Cancer Res 2008 Sep;68(17):7228-36

The Center for Cell and Gene Therapy, Department of Immunology, Baylor College of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-1245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181121PMC
September 2008

CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.

Clin Cancer Res 2007 Dec;13(23):6947-58

Department of Pathology, The Center for Cell and Gene Therapy, Baylor Colleg of Medicine, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-0842DOI Listing
December 2007

Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.

Immunity 2007 Aug 26;27(2):334-48. Epub 2007 Jul 26.

The Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2007.05.020DOI Listing
August 2007

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function.

Science 2005 Aug;309(5739):1380-4

Center for Cell and Gene Therapy and Department of Immunology, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.1113401DOI Listing
August 2005

The effect of ligustrazine on peritoneal transport in peritoneal dialysis.

J Huazhong Univ Sci Technolog Med Sci 2002 ;22(4):334-6

Department of Nephrology, Xiehe Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/bf02896779DOI Listing
July 2004

Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice.

J Immunol 2003 Feb;170(3):1267-73

Department of Immunology, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.170.3.1267DOI Listing
February 2003